DI STEFANO, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 4.560
EU - Europa 2.160
AS - Asia 1.973
SA - Sud America 260
Continente sconosciuto - Info sul continente non disponibili 193
AF - Africa 50
OC - Oceania 13
Totale 9.209
Nazione #
US - Stati Uniti d'America 4.471
SG - Singapore 763
RU - Federazione Russa 594
CN - Cina 501
IT - Italia 323
FI - Finlandia 282
UA - Ucraina 244
HK - Hong Kong 223
BR - Brasile 197
DE - Germania 163
VN - Vietnam 150
IE - Irlanda 114
GB - Regno Unito 101
PL - Polonia 95
FR - Francia 87
JP - Giappone 78
SE - Svezia 57
IN - India 47
BD - Bangladesh 44
CA - Canada 41
KR - Corea 21
IQ - Iraq 20
MX - Messico 18
NL - Olanda 18
RO - Romania 17
CO - Colombia 16
TR - Turchia 16
VE - Venezuela 16
AR - Argentina 14
AU - Australia 13
BE - Belgio 13
ID - Indonesia 12
UZ - Uzbekistan 12
AT - Austria 10
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 10
JM - Giamaica 10
SA - Arabia Saudita 10
EC - Ecuador 9
PK - Pakistan 9
KE - Kenya 7
MA - Marocco 7
NP - Nepal 7
PH - Filippine 7
ZA - Sudafrica 7
JO - Giordania 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
EG - Egitto 5
ES - Italia 5
IR - Iran 5
AM - Armenia 4
DZ - Algeria 4
LB - Libano 4
PS - Palestinian Territory 4
TH - Thailandia 4
BG - Bulgaria 3
BY - Bielorussia 3
CL - Cile 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
HN - Honduras 3
OM - Oman 3
PY - Paraguay 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
CH - Svizzera 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
EU - Europa 1
GH - Ghana 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LY - Libia 1
MC - Monaco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NG - Nigeria 1
PA - Panama 1
Totale 9.017
Città #
Singapore 550
Ashburn 539
Fairfield 470
San Jose 317
Woodbridge 266
Chandler 227
Hong Kong 213
Houston 194
Wilmington 174
Seattle 163
Cambridge 150
Ann Arbor 149
Jacksonville 132
Dublin 114
Moscow 88
Zgierz 84
Des Moines 78
Los Angeles 77
Medford 77
Tokyo 77
Beijing 76
Frankfurt am Main 68
Nanjing 67
Council Bluffs 63
Santa Clara 62
New York 58
Palermo 57
Ho Chi Minh City 51
Princeton 47
Altamura 41
Boardman 41
Lauterbourg 39
Hanoi 34
San Diego 34
Chicago 33
Lawrence 33
Dallas 32
Tulsa 32
Helsinki 28
Shenyang 24
Buffalo 23
Milan 23
Hefei 22
Jinan 16
Nanchang 16
São Paulo 16
The Dalles 16
Dearborn 15
Changsha 14
Jiaxing 14
Atlanta 13
London 12
Seongnam 12
Tianjin 12
Zhengzhou 12
Brussels 11
Hebei 11
Izmir 11
Kumar 11
Amsterdam 10
Columbus 10
Montreal 10
Orem 10
Abidjan 9
Baghdad 9
Denver 9
Philadelphia 9
Tashkent 9
Guangzhou 8
Haiphong 8
Rio de Janeiro 8
Rome 8
Saint Petersburg 8
Durham 7
Las Vegas 7
Ludwigshafen am Rhein 7
Toronto 7
Bexley 6
Biên Hòa 6
Brno 6
Brooklyn 6
Central District 6
Chennai 6
City of London 6
Curitiba 6
Hangzhou 6
Kunming 6
Lake Forest 6
Nairobi 6
Newark 6
Norwalk 6
Nuremberg 6
Ottawa 6
Porto Alegre 6
San Francisco 6
San Mateo 6
San Paolo di Civitate 6
Washington 6
Amman 5
Auburn Hills 5
Totale 5.628
Nome #
Hepatitis B virus reactivation and alemtuzumab therapy 339
HCV genotypes in Sicily: is there any evidence of a shift? 331
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 310
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin 306
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay 285
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection 270
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 264
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial 257
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 253
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy 247
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. 241
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 233
Phylogenetic Reconstruction of HCV Genotype 1b Dissemination in a Small City Centre: The Camporeale Model 233
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome 221
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial 221
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 221
Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission 218
Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity 214
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction 207
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study 206
Infezione occulta da HBV in pazienti con malattie linfoproliferative in trattamento chemioterapico 198
Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir 195
HCV genotypes in western Sicily: any evidence for a shift? 195
EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? 195
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. 193
Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier 186
Modulation of epitope-specific anti-hepatitis C virus E2(anti-HCV/E2)antibodies by anti-viral treatment 185
Sustained response after lamivudine treatment in HBe minus chronic hepatitis B 181
Infezione occulta da HBV nel paziente immunocompromesso.studio dell'eterogeneità virale 177
Infezione occulta da HBV in pazienti con malattie oncoematologiche 177
Epidemiologia molecolare dell'infezione da HCV in un Comune Siciliano 177
VARIABILITY OF THE HBV POL GENE REVERSE-TRANSCRIPTASE DOMAIN IN VIRAL ISOLATES FROM UNTREATED AND LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B PATIENTS 176
Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) 172
Flaviviridae 157
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 153
Hepatitis C virus clearance and gender 151
Riattivazione dell'infezione occulta da HBV nel paziente immunocompromesso:studio dell'eterogeneità virale 142
Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV 142
PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? 138
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 133
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 133
ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin 128
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 120
Viral Sequence Analysis of Occult HBV Infection and Its Reactivation in Immunosuppressed Patients 116
Rhabdoviridae 112
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE 100
Totale 9.209
Categoria #
all - tutte 29.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022344 0 0 0 16 13 17 22 16 68 64 28 100
2022/2023651 71 131 9 58 79 103 51 38 61 2 28 20
2023/2024239 21 35 16 30 29 42 14 14 6 12 0 20
2024/2025817 14 50 41 86 28 36 49 59 68 88 105 193
2025/20263.030 187 78 124 178 245 478 426 329 229 513 113 130
2026/2027752 109 87 416 140 0 0 0 0 0 0 0 0
Totale 9.209